Historical Valuation
Definitive Healthcare Corp (DH) is now in the Fair zone, suggesting that its current forward PE ratio of 9.19 is considered Fairly compared with the five-year average of 49.65. The fair price of Definitive Healthcare Corp (DH) is between 1.06 to 22.98 according to relative valuation methord.
Relative Value
Fair Zone
1.06-22.98
Current Price：2.55
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Definitive Healthcare Corp (DH) has a current Price-to-Book (P/B) ratio of 0.86. Compared to its 3-year average P/B ratio of 1.07 , the current P/B ratio is approximately -19.54% higher. Relative to its 5-year average P/B ratio of 1.58, the current P/B ratio is about -45.68% higher. Definitive Healthcare Corp (DH) has a Forward Free Cash Flow (FCF) yield of approximately 14.68%. Compared to its 3-year average FCF yield of 7.08%, the current FCF yield is approximately 107.20% lower. Relative to its 5-year average FCF yield of 5.31% , the current FCF yield is about 176.20% lower.
P/B
Median3y
1.07
Median5y
1.58
FCF Yield
Median3y
7.08
Median5y
5.31
Competitors Valuation Multiple
AI Analysis for DH
The average P/S ratio for DH competitors is 1.56, providing a benchmark for relative valuation. Definitive Healthcare Corp Corp (DH.O) exhibits a P/S ratio of 1.05, which is -32.93% above the industry average. Given its robust revenue growth of -4.23%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for DH
1Y
3Y
5Y
Market capitalization of DH increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of DH in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is DH currently overvalued or undervalued?
Definitive Healthcare Corp (DH) is now in the Fair zone, suggesting that its current forward PE ratio of 9.19 is considered Fairly compared with the five-year average of 49.65. The fair price of Definitive Healthcare Corp (DH) is between 1.06 to 22.98 according to relative valuation methord.
What is Definitive Healthcare Corp (DH) fair value?
DH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Definitive Healthcare Corp (DH) is between 1.06 to 22.98 according to relative valuation methord.
How does DH's valuation metrics compare to the industry average?
The average P/S ratio for DH's competitors is 1.56, providing a benchmark for relative valuation. Definitive Healthcare Corp Corp (DH) exhibits a P/S ratio of 1.05, which is -32.93% above the industry average. Given its robust revenue growth of -4.23%, this premium appears unsustainable.
What is the current P/B ratio for Definitive Healthcare Corp (DH) as of Jan 10 2026?
As of Jan 10 2026, Definitive Healthcare Corp (DH) has a P/B ratio of 0.86. This indicates that the market values DH at 0.86 times its book value.
What is the current FCF Yield for Definitive Healthcare Corp (DH) as of Jan 10 2026?
As of Jan 10 2026, Definitive Healthcare Corp (DH) has a FCF Yield of 14.68%. This means that for every dollar of Definitive Healthcare Corp’s market capitalization, the company generates 14.68 cents in free cash flow.
What is the current Forward P/E ratio for Definitive Healthcare Corp (DH) as of Jan 10 2026?
As of Jan 10 2026, Definitive Healthcare Corp (DH) has a Forward P/E ratio of 9.19. This means the market is willing to pay $9.19 for every dollar of Definitive Healthcare Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Definitive Healthcare Corp (DH) as of Jan 10 2026?
As of Jan 10 2026, Definitive Healthcare Corp (DH) has a Forward P/S ratio of 1.05. This means the market is valuing DH at $1.05 for every dollar of expected revenue over the next 12 months.